Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2019 Filed Apr 4, 2019 20:09 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
SaleCommon Stock | 2,000 | $62.60 | $125,200.00 |
DisclosureSEC source: 0001209191-19-023629 · doc4.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 F2 · shares: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| April 03, 2019 Filed Apr 4, 2019 20:09 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
Exercise / conversionCommon Stock | 2,000 | $2.59 | $5,180.00 |
DisclosureSEC source: 0001209191-19-023629 · doc4.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 23:07 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-019842 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 23:07 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 10,000 | $72.00 | $720,000.00 |
DisclosureSEC source: 0001209191-19-019842 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 23:07 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $2.59 | $25,900.00 |
DisclosureSEC source: 0001209191-19-019842 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 23:10 UTC |
BLICKENSTAFF KIM DDirector · Executive Chairman
|
SaleCommon Stock | 15,954 | $65.67 | $1,047,699.18 |
DisclosureSEC source: 0001209191-19-019237 · doc4.xml · nonDerivative · entry 2 BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 991,750 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.51 and $65.795. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 23:10 UTC |
BLICKENSTAFF KIM DDirector · Executive Chairman
|
SaleCommon Stock | 184,046 | $64.89 | $11,942,744.94 |
DisclosureSEC source: 0001209191-19-019237 · doc4.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,007,704 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $64.50 and $65.4925. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 300 | $63.21 | $18,963.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 7 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,000 F9 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.20 and $63.24. F8 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 3,803 | $62.79 | $238,790.37 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 6 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,300 F7 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.1734 and $63.16. F8 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 418 | $62.53 | $26,137.54 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 5 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F6 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 418 | $62.53 | $26,137.54 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F5 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 6,300 | $62.29 | $392,427.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F4 · ownership.nature: The securities are held in the Mary Allen Roth IRA. The Reporting Person is married to Mary Allen, and the Reporting Person may be deemed to have indirect beneficial ownership of such securities held in the Mary Allen Roth IRA. The Reporting Person disclaims beneficial ownership of such securities held in the Mary Allen Roth IRA. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 200 | $63.22 | $12,644.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.19 and $63.245. F2 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC |
Allen DickDirector
|
SaleCommon Stock | 6,100 | $62.71 | $382,531.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.19 and $63.18. F2 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 22:32 UTC |
CAHILL EDWARD LDirector
|
OtherCommon Stock | 3,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-018219 · doc4.xml · nonDerivative · entry 2 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,982 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 22:32 UTC |
CAHILL EDWARD LDirector
|
OtherCommon Stock | 17,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-018219 · doc4.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By HLM Venture Associates II, L.L.C Disclosed balance after: 0 F1 · shares: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by HLM Venture Associates II, L.L.C. effected following the close of the trading market on March 6, 2019. As a result of the distribution, the reporting owner is the beneficial owner of 3,982 shares of common stock. F2 · ownership.nature: The Reporting Person is a managing member of HLM Venture Associates II, L.L.C. and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of record by HLM Venture Associates II, L.L.C. The Reporting Person disclaims beneficial ownership of any such securities held of record by HLM Venture Associates II, L.L.C, except to the extent of his respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionStock Option · Derivative | 1,282 | $0.00 Strike: $11.06 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 10 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,145 Underlying: Common Stock · 1,282 shares Expires 2023-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionStock Option · Derivative | 4,121 | $0.00 Strike: $11.06 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 9 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,121 shares Expires 2023-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionStock Option · Derivative | 4,597 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 8 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,903 Underlying: Common Stock · 4,597 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionStock Option · Derivative | 50,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · derivative · entry 7 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 50,000 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
SaleCommon Stock | 25,354 | $68.39 | $1,733,960.06 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 6 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,745 F2 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $68.00 to $68.89. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
SaleCommon Stock | 34,646 | $67.35 | $2,333,408.10 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 5 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,099 F1 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $67.00 to $67.99. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionCommon Stock | 1,282 | $11.06 | $14,177.64 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 4 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionCommon Stock | 4,121 | $11.06 | $45,574.14 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionCommon Stock | 4,597 | $9.00 | $41,373.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 00:24 UTC |
Morrison SusanEVP & CAO
|
Exercise / conversionCommon Stock | 50,000 | $2.59 | $129,500.00 |
DisclosureSEC source: 0001209191-19-016013 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 17:58 UTC |
GREENE HOWARD E JRDirector
|
SaleCommon Stock | 2,400 | $66.21 | $158,904.00 |
DisclosureSEC source: 0001209191-19-015149 · doc4.xml · nonDerivative · entry 4 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 40,000 F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $66.03 and $66.53. F2 · ownership.nature: The securities are held by the Greene Family Trust. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 17:58 UTC |
GREENE HOWARD E JRDirector
|
SaleCommon Stock | 5,600 | $65.68 | $367,808.00 |
DisclosureSEC source: 0001209191-19-015149 · doc4.xml · nonDerivative · entry 3 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 42,400 F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.01 and $65.96. F2 · ownership.nature: The securities are held by the Greene Family Trust. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 17:58 UTC |
GREENE HOWARD E JRDirector
|
SaleCommon Stock | 800 | $64.30 | $51,440.00 |
DisclosureSEC source: 0001209191-19-015149 · doc4.xml · nonDerivative · entry 2 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 48,000 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.95 and $64.55. F2 · ownership.nature: The securities are held by the Greene Family Trust. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 17:58 UTC |
GREENE HOWARD E JRDirector
|
SaleCommon Stock | 1,200 | $63.11 | $75,732.00 |
DisclosureSEC source: 0001209191-19-015149 · doc4.xml · nonDerivative · entry 1 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 48,800 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.77 and $63.45. F2 · ownership.nature: The securities are held by the Greene Family Trust. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock · Derivative | 1,667 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · derivative · entry 7 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 1,667 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock · Derivative | 18,333 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · derivative · entry 6 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Stock · 18,333 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
SaleCommon Stock | 3,800 | $62.53 | $237,614.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · nonDerivative · entry 4 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 F3 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2018, in multiple transactions at prices ranging from $62.51 to $62.62. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
SaleCommon Stock | 16,200 | $61.91 | $1,002,942.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · nonDerivative · entry 3 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,466 F2 · price: The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2018, in multiple transactions at prices ranging from $61.50 to $62.50. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 1,667 | $9.00 | $15,003.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 18,333 | $2.59 | $47,482.47 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:39 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
GrantCommon Stock · Derivative | 105,000 | $0.00 Strike: $48.36 | $0.00 |
DisclosureSEC source: 0001209191-19-014215 · doc4.xml · derivative · entry 5 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F5 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/25/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter F6 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:12 UTC |
Vosseller LeighEVP and CFO
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011506 · doc4.xml · derivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:11 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011505 · doc4.xml · derivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:08 UTC |
Morrison SusanEVP & CAO
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011500 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:07 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011499 · doc4.xml · derivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:06 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
GrantStock Option · Derivative | 210,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011496 · doc4.xml · derivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:05 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001209191-19-011492 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| January 25, 2019 Filed Jan 25, 2019 22:55 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-005412 · doc4.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 20,000 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter Read SEC document |
| January 25, 2019 Filed Jan 25, 2019 22:55 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
SaleCommon Stock | 20,000 | $45.26 | $905,178.00 |
DisclosureSEC source: 0001209191-19-005412 · doc4.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 F2 · price: The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29,2018, in multiple transactions at prices ranging from $45.00 to $45.81. Read SEC document |
| January 25, 2019 Filed Jan 25, 2019 22:55 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 20,000 | $2.59 | $51,800.00 |
DisclosureSEC source: 0001209191-19-005412 · doc4.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 21:45 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 25,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-003728 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 21:45 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 25,000 | $41.54 | $1,038,527.50 |
DisclosureSEC source: 0001209191-19-003728 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.25 and $41.93. Read SEC document |
| January 15, 2019 Filed Jan 15, 2019 21:45 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 25,000 | $2.59 | $64,750.00 |
DisclosureSEC source: 0001209191-19-003728 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 08, 2019 Filed Jan 9, 2019 22:19 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-003104 · doc4.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.